Skip to content
zameds

Mavacoxib (Trocoxil For Dogs)

Mavacoxib

Zoetis South Africa (Pty) Ltd

S4

Registration

Applicant
Zoetis South Africa (Pty) Ltd
Registrations
5
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Trocoxil chewable tablets for dogs 6 MG

EACH TABLET CONTAINS MAVACOXIB 6,0 mg

6 mgChewable tablets1-Nov11/3.1.2.2/01CancelledS4None
Trocoxil chewable tablets for dogs 20 MG

EACH TABLET CONTAINS MAVACOXIB 20,0 mg

20 mgChewable tablets2-Nov11/3.1.2.2/02RegisteredS4None
Trocoxil chewable tablets for dogs 30 MG

EACH TABLET CONTAINS MAVACOXIB 30,0 mg

30 mgChewable tablets3-Nov11/3.1.2.2/03RegisteredS4None
Trocoxil chewable tablets for dogs 75 MG

EACH TABLET CONTAINS MAVACOXIB 75,0 mg

75 mgChewable tablets4-Nov11/3.1.2.2/04RegisteredS4None
Trocoxil chewable tablets for dogs 95 MG

EACH TABLET CONTAINS MAVACOXIB 95,0 mg

95 mgChewable tablets5-Nov11/3.1.2.2/05RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Mavacoxib

  • S4: Mavacoxib

    Consolidated Schedules 06 July 2026, line 7010

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C16H11F4N3O2S385.30 g/mol

4-[5-(4-Fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

Drag to rotate. Structure from PubChem CID 9843089.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles